Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), By Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,340.4 million in 2020 and is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4224
Neurovascular devices are extensively used for treatment of neurovascular diseases such as brain aneurysms, arteriovenous malformations (AVMs), and others. The global neurovascular devices market is expected to witness significant growth during the forecast period, owing to the increasing number of product approvals and launches by key players.
For instance, in June 2018, Terumo announced that SOFIA catheter designed for distal navigation and successful revascularization of patients received FDA clearance.
For instance, in April 2019, Medtronic announced the launch of its fourth-generation Solitaire X revascularization device, which is designed for treatment of AIS (acute ischemic stroke). This neurovascular device expands on Drop Zone and Smart Maker technologies.
For instance, in 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for acute ischemic stroke treatment. The device includes latest technology that is designed to deliver aspiration power to its full strength so as to extract thrombus in acute ischemic stroke.
Quick Buy – Neurovascular Devices Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4224
Global Neurovascular Devices Market – Impact of Coronavirus (Covid-19) Pandemic
The rapid spread of COVID-19 is challenging healthcare systems worldwide. In many countries, hospitals and ICU departments are overloaded or fearing potential collapse of healthcare resources that are required for treatments in ICU.
Healthcare professionals are forced to treat severely ill patients with limited access to ventilation equipment, qualified intensive care personnel or protective patient monitoring devices.
Since December 2019, a novel coronavirus spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time. The disease has spread to more than 200 countries across the globe with the World Health Organization declaring it a public health emergency.
According to the World Health Organization Coronavirus Disease (COVID-19) Dashboard (WHO) report, the manifestation of the coronavirus disease (COVID-19) has resulted in more than 31 million infected individuals worldwide as of September 22, 2020.
Browse 26 Market Data Tables and 42 Figures spread through 329 Pages and in-depth TOC on Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), by Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Forecast to 2027″.
To know the latest trends and insights related to neurovascular devices market press Release, click the link below: https://www.coherentmarketinsights.com/press-release/neurovascular-devices-market-3494
Key Takeaways of the Neurovascular Devices Market:
- The global neurovascular devices market is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027), owing to increasing product approvals and launches
- Among device type, the embolic protection devices segment is expected to hold a major revenue share in 2027, owing to the increasing launching of advanced products in the market for better outcomes of neurosurgeries. For instance, in September 2017, Medtronic announced the launch of the Concerto 3D detachable coil system. The Concerto 3D coil is a new coil in the Medtronic Concerto platform and is indicated for arterial and venous embolizations in the peripheral vasculature. The product is available in both the U.S. and Europe.
- Major players operating in the global neurovascular devices market include Medtronic Plc., Abbott Laboratories, Johnson & Johnson, Merit Medical Systems, Inc., Stryker Corporation, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, and Cerus Endovascular Limited
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Device Type
- Market Snippet, By Therapeutic Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Product Launches/Approvals
- Agreements And Acquisitions
- Regulatory Framework
- Porter’s Analysis
- Technological Advancement
- Market Dynamics
- Impact Analysis of Covid-19
- During-COVID 19 Market Analysis
- Supply side and Demand side Analysis
- Overall Impact
- Global Neurovascular Devices Market, By Device Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Embolization Coils
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Platinum Coils
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Coated Platinum Coils
- Liquid Embolic Coils
- Platinum Coils
- Neurovascular Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Carotid Artery Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Flow Diversion Stents
- Carotid Artery Stents
- Neurothrombectomy devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Clot Retrievers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Aspiration/ Suction Devices
- Vascular Snares
- Clot Retrievers
- Embolic Protection Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Distal Filter Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Balloon Occlusion Devices
- Distal Filter Devices
- Neurovascular Supporting Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Microcatheters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Microguidewires
- Microcatheters
- Introduction
- Global Neurovascular Devices Market, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Cerebral Aneurysms
- Ischemic Stroke
- Cerebral Artery Stenosis
- Arteriovenous Malformations (AVMs) and AV Fistulas
- Others
- Introduction
- Global Neurovascular Devices Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Therapeutic Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Medtronic Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbott Laboratories
- Johnson & Johnson
- Merit Medical Systems, Inc.
- Stryker Corporation
- Penumbra, Inc.
- Acandis GmbH & Co. KG
- MicroPort Scientific Corporatio
- Terumo Corporation
- Cerus Endovascular Limited
- Medtronic Plc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Need a discount?
Note: *The discount is offered on the Standard Price of the report.
Request discount for this report @ https://www.coherentmarketinsights.com/insight/request-discount/4224
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
